Nucleic Acid Isolation And Purification Market Summary

The global nucleic acid isolation and purification market size was estimated at USD 5.75 billion in 2024 and is projected to reach USD 9.77 billion by 2030, growing at a CAGR of 9.61% from 2025 to 2030. The nucleic acid isolation and purification (NAIP) market expansion is fueled by several factors, such as the rise in adoption of sequencing platforms for clinical diagnostics, growth in genomics and enzymology-based research, and an increase in investments in R&D. Growing applications of nucleic acids in disease diagnosis, pharmaceutical development, and personalized therapies are also significantly contributing to market development.

In addition, the potential of molecular biology and advancement in precision medicine are further augmenting market growth. Increasing efforts of market participants to strengthen manufacturing capacity is facilitating market expansion. For instance, in January 2023, Agilent Technologies announced an investment of USD 725 million to increase the manufacturing capacity of therapeutic nucleic acids. Collaborations between academic institutions and industry players, along with the introduction of automated and high-throughput purification systems, are also enhancing product adoption.

Key Market Trends & Insights

  • North America was the largest revenue-generating market in 2024. Well-established healthcare infrastructure, availability of advanced laboratory technologies, and rising awareness regarding genomics-based applications have supported this dominance.
  • The U.S. is expected to grow due to increasing demand for genetic testing, rising adoption of precision medicine, and advancements in molecular diagnostics. Supportive government initiatives and funding for genome-based projects also contribute to the country’s strong growth potential.
  • By product, kits and reagents accounted for the largest revenue in 2024. Their widespread use in routine laboratory procedures and growing preference for ready-to-use solutions in research workflows bolster their demand.
  • By type, the DNA isolation and purification segment held the highest market share in 2024. Higher application of DNA in genetic testing, biomarker discovery, and disease monitoring drives the segment’s leadership.

Order a free sample PDF of the Nucleic Acid Isolation And Purification Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

  • 2024 Market Size: USD 5.75 Billion
  • 2030 Projected Market Size: USD 9.77 Billion
  • CAGR (2025-2030): 9.61%
  • North America: Largest market in 2024
  • Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Many companies in the nucleic acid isolation & purification market are aiming for product approvals and launch to strengthen their market position. In addition, companies are undertaking regional expansions and collaborations to increase the manufacturing capacity and sharing of technologies to develop efficient nucleic acid isolation and purification solutions.

Key Players

  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Danaher
  • Hoffmann-La Roche Ltd
  • Merck KGaA
  • Agilent Technologies
  • Bio-Rad Laboratories, Inc.
  • Takara Bio Inc.
  • Promega Corporation

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The nucleic acid isolation and purification market is anticipated to witness strong growth due to the rapidly expanding fields of genomics, personalized medicine, and molecular diagnostics. The rising prevalence of genetic disorders and infectious diseases has increased the need for high-quality purified nucleic acids, boosting product utilization across clinical and research settings. Continuous improvements in automated purification technologies and expansion of manufacturing capabilities by leading companies support market development. North America remains a significant contributor due to its advanced healthcare infrastructure. With ongoing investments and innovation in life sciences, the market is expected to play a crucial role in future biomedical advancements.